<DOC>
	<DOCNO>NCT00002411</DOCNO>
	<brief_summary>The purpose study compare safety didanosine plus stavudine plus nelfinavir ( NLF ) zidovudine plus lamivudine plus NLF . This study also examine long drug combination effective lower viral load ( level HIV blood ) .</brief_summary>
	<brief_title>A Comparison Two Triple-Drug Combinations Patients Who Have Never Been Treated With Anti-HIV Drugs</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Nelfinavir</mesh_term>
	<mesh_term>Stavudine</mesh_term>
	<mesh_term>Didanosine</mesh_term>
	<mesh_term>Zidovudine</mesh_term>
	<mesh_term>Lamivudine</mesh_term>
	<criteria>Inclusion Criteria Patients must : Within 15 business day prior randomization : CD4 cell count great equal 100 cells/mm3 . HIV RNA great equal 2,000 copies/ml Roche Amplicor Assay . Exclusion Criteria Coexisting Condition : Patients follow symptoms condition exclude : Bilateral peripheral neuropathy . Intractable diarrhea . Proven suspect acute hepatitis within 30 day prior study entry . Concurrent Medication : Excluded : Therapy coexist disease may interfere patient ability participate study . Concurrent Treatment : Excluded : Therapy coexist disease may interfere patient ability participate study . Patients follow prior condition exclude : History acute chronic pancreatitis . Prior Medication : Excluded : Therapy previous disease may interfere patient ability participate study . Excluded within 14 day prior randomization : Greater 4 week nucleoside therapy great 1 week protease inhibitor therapy . Excluded within 3 month start study expect need time enrollment : Agents significant systemic myelosuppressive , neurotoxic , pancreatoxic , hepatotoxic , cytotoxic potential . Inability tolerate oral medication . Prior Treatment : Excluded : Therapy previous disease may interfere patient ability participate study . Risk Behavior : Excluded : Active alcohol substance abuse , opinion investigator , sufficient prevent adequate compliance study therapy increase risk develop pancreatitis .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>HIV-1</keyword>
	<keyword>Didanosine</keyword>
	<keyword>Drug Therapy , Combination</keyword>
	<keyword>Zidovudine</keyword>
	<keyword>Stavudine</keyword>
	<keyword>Lamivudine</keyword>
	<keyword>RNA , Viral</keyword>
	<keyword>Nelfinavir</keyword>
	<keyword>Anti-HIV Agents</keyword>
	<keyword>Viral Load</keyword>
</DOC>